Um... that was exactly what Karim and thero said. I don't think you understand why cprx was successful. The sp was useless at $1.00 to do public offerings, now $17 they can do small share public offerings for many multiples of the sp at $1.00. Your thinking is exactly why amrn failed. Start a buyback, wait till the sp is at $17 or $20 and then, and only then do small incremental offerings as needed. Sp needs to be much higher and that's why your thinking with thero and Karim will continue to fail. Cprx is living proof
News 
Market Data 
Discover 
AI
